TECHNEGAS KIT
Growthkit for the preparation of technetium tc 99m-labeled carbon inhalation aerosol
NDAINHALATIONAEROSOL
Approved
Sep 2023
Lifecycle
Growth
Competitive Pressure
8/100
Data completeness
3/8 — Basic
TECHNEGAS KIT (kit for the preparation of technetium tc 99m-labeled carbon inhalation aerosol) by Cyclomedica is inhaled, they are mechanically deposited on the epithelium of ventilated pulmonary bronchioles and alveoli. First approved in 2023.
Drug data last refreshed 9h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECHNEGAS KIT is a diagnostic radiopharmaceutical kit used to prepare technetium Tc-99m labeled carbon aerosol for inhalation imaging of pulmonary ventilation. The inhaled aerosol mechanically deposits on the epithelium of ventilated bronchioles and alveoli, with distribution determined by lung aerodynamic function rather than receptor-mediated mechanisms. It is used for functional assessment of regional lung ventilation in patients with suspected pulmonary disease.
LOE Approaching4.7 years to LOE
Product faces imminent loss of exclusivity (September 2026), signaling a small, defense-focused team managing regulatory transition rather than growth.
Mechanism of Action
inhaled, they are mechanically deposited on the epithelium of ventilated pulmonary bronchioles and alveoli. Localization of the aerosol is not mediated by specific pharmacologic receptors; rather the distribution is determined by the aerodynamic function of the lungs.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
LOE in ~5 years — strategic planning for patent cliff underway
Worked on TECHNEGAS KIT at Cyclomedica? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.